Verve Therapeutics, Inc. stock forum
VERV Verve Therapeutics' stock has risen significantly today, December 2, 2024, following positive updates related to its ongoing clinical trials and broader confidence in its gene-editing technology. The market responded enthusiastically to recent data suggesting advancements in Verve's lead programs, including VERVE-101, which targets PCSK9 to reduce LDL cholesterol in patients with atherosclerotic cardiovascular disease.
VERV anybody here?